)

ImmunoPrecise Antibodies (IPA) investor relations material
ImmunoPrecise Antibodies Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Achieved record Q1 revenue of $7.6 million, up 45% year over year, with gross profit of $4 million and a 53% margin.
Operating loss narrowed to $2.7 million, adjusted EBITDA loss halved to $1.4 million, and net loss improved to $3 million.
Completed divestiture of Netherlands operations for $16.1 million, strengthening the balance sheet and focusing on high-margin, strategic initiatives.
Rebranded as MindWalk Inc., unifying legacy companies and introducing new Nasdaq ticker HYFT, emphasizing a bio-native AI platform model.
Cash balance at quarter-end was $5 million, with an additional $16.1 million from the divestiture.
Financial highlights
Q1 revenue reached $7.6 million, a 45% year-over-year increase, including $3.2 million from continuing and $4.4 million from discontinued operations.
Gross profit rose to $4 million (53% margin), with continued operations at $1.5 million (48% margin) and discontinued at $2.5 million (56% margin).
Operating loss (excluding amortization and non-recurring charges) improved to $2.7 million from $4.2 million.
Adjusted EBITDA loss improved to $1.4 million from $2.8 million year over year.
Net loss improved to $3 million from $4 million last year.
Outlook and guidance
Focused on expanding SaaS, data as a service, and translational programs, including the dengue vaccine initiative.
Anticipates stronger gross margin contributions from BioStrand and continued growth in core AI-driven operations.
Rebranding and platform integration expected to drive new partnerships and scalable growth.
Management expects sustainable growth and long-term value, supported by a stronger capital structure and focus on scalable AI-driven opportunities.
Ongoing transformation into a fully integrated BioIntelligence company, with continued investment in AI and biologics platforms.
Next ImmunoPrecise Antibodies earnings date

Next ImmunoPrecise Antibodies earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage